# ESPR (Esperion Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Esperion Therapeutics, Inc. reported $418.2M in revenue and a net loss of $7.42M for the trailing twelve months ended March 31, 2026 (up 23.2% year over year), with a 18.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/ESPR
- Markdown: https://convexityos.com/fundamentals/ESPR.md
- SEC CIK: 0001434868
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:34 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001434868&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $418.2M | +23.2% YoY |
| Operating Income | TTM | $75.79M | 18.1% margin |
| Net Income | TTM | -$7.42M | -1.8% net margin |
| Diluted EPS | TTM | -$0.03 | Split-adjusted |
| Free Cash Flow | TTM | -$18.38M | -4.4% FCF margin |
| Cash & ST Investments | Mar 31, 2026 | $156.2M | Total debt: $2.56M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $403.1M | $332.3M | $116.3M | $75.47M | $78.45M | $227.5M | $148.4M | $0 | -- | -- |
| Research & Development | $47.85M | $46.24M | $86.11M | $118.9M | $106.0M | $146.9M | $175.6M | $171.5M | $147.6M | $57.87M |
| Selling, General & Admin | $165.8M | $163.1M | $142.5M | $109.1M | $185.0M | $199.6M | $65.85M | $33.10M | -- | -- |
| Total Operating Expenses | $342.9M | $277.9M | $271.9M | $255.0M | $305.2M | $348.9M | $241.5M | $204.6M | $169.0M | $76.15M |
| **Operating Income** | $60.27M | $54.40M | -$155.6M | -$179.5M | -$226.7M | -$121.4M | -$93.10M | -$204.6M | -$169.0M | -$76.15M |
| **EBITDA** | $60.38M | $54.47M | -$155.4M | -$179.0M | -$226.1M | -$120.8M | -$92.78M | -$204.3M | -$168.7M | -$75.90M |
| Interest Expense | $84.60M | $59.25M | $58.98M | $56.81M | $46.35M | $22.67M | $8.12M | $28K | $198K | $376K |
| Income Before Tax | -$20.84M | -$51.74M | -$209.2M | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $1.84M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$22.68M | -$51.74M | -$209.2M | -$233.7M | -$269.1M | -$143.6M | -$97.17M | -$201.8M | -$167.0M | -$74.98M |
| Basic EPS | -$0.11 | -$0.28 | -$2.03 | -$3.52 | -$9.31 | -$5.23 | -$3.59 | -$7.54 | -$6.98 | -$3.33 |
| **Diluted EPS** | -$0.11 | -$0.28 | -$2.03 | -$3.52 | -$9.31 | -$5.23 | -$3.59 | -$7.54 | -$6.98 | -$3.33 |
| Basic Shares Outstanding | 207.9M | 187.2M | 103.1M | 66.4M | 28.9M | 27.5M | 27.1M | 26.8M | 23.9M | 22.5M |
| Diluted Shares Outstanding | 207.9M | 187.2M | 103.1M | 66.4M | 28.9M | 27.5M | 27.1M | 26.8M | 23.9M | 22.5M |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $80.10M | $168.4M | $87.31M | $82.39M | $65.00M | $69.11M | $51.63M | $73.83M |
| Research & Development | $8.99M | $13.93M | $14.13M | $7.24M | $12.56M | $10.98M | $10.40M | $11.46M |
| Selling, General & Admin | $43.12M | $41.43M | $41.85M | $39.51M | $43.00M | $36.92M | $39.98M | $44.19M |
| Total Operating Expenses | $86.69M | $83.21M | $97.27M | $75.29M | $87.09M | $73.53M | $67.66M | $71.25M |
| **Operating Income** | -$6.58M | $85.23M | -$9.96M | $7.09M | -$22.10M | -$4.42M | -$16.03M | $2.58M |
| **EBITDA** | -$6.55M | $85.26M | -$9.93M | $7.12M | -$22.07M | -$4.39M | -$16.00M | $2.59M |
| Interest Expense | $19.80M | $22.64M | $22.05M | $20.49M | $19.43M | $16.42M | $15.08M | $13.72M |
| Income Tax Expense | $0 | $1.84M | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$25.20M | $61.83M | -$31.33M | -$12.72M | -$40.45M | -$21.32M | -$29.52M | -$61.92M |
| Basic EPS | -$0.10 | -- | -$0.16 | -$0.06 | -$0.21 | -- | -$0.15 | -$0.33 |
| **Diluted EPS** | -$0.10 | -- | -$0.16 | -$0.06 | -$0.21 | -- | -$0.15 | -$0.33 |
| Basic Shares Outstanding | 251.4M | -- | 200.7M | 197.5M | 196.1M | -- | 194.9M | 188.8M |
| Diluted Shares Outstanding | 251.4M | -- | 200.7M | 197.5M | 196.1M | -- | 194.9M | 188.8M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $167.9M | $144.8M | $82.25M | $124.8M | $208.9M | $305.0M | $166.1M | $36.97M | $34.47M | $38.16M |
| Short-Term Investments | -- | -- | $0 | $42.09M | $50.44M | $0 | $34.65M | $99.05M | $165.7M | -- |
| **Cash & Short-Term Investments** | $167.9M | $144.8M | $82.25M | $166.9M | $259.3M | $305.0M | $200.8M | $136.0M | $200.2M | $38.16M |
| Accounts Receivable, Net | $140.2M | $80.14M | $48.49M | $33.73M | $22.93M | $12.39M | -- | -- | -- | -- |
| Inventory | $105.1M | $94.49M | $65.62M | $35.20M | $34.39M | $16.14M | $0 | -- | -- | -- |
| **Total Current Assets** | $462.6M | $338.0M | $201.1M | $246.7M | $329.0M | $345.9M | $211.7M | $142.6M | $203.9M | $213.6M |
| Property, Plant & Equipment, Net | $338K | $254K | $0 | $164K | $664K | $1.28M | $1.15M | $520K | $435K | $674K |
| Intangible Assets | -- | -- | -- | $56K | $56K | $56K | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $243K | $73.42M | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $56K | -- | -- | -- |
| **Total Non-Current Assets** | $3.32M | $5.82M | $4.73M | $1.26M | $52.62M | $7.36M | $2.73M | $819K | $73.91M | $31.64M |
| **Total Assets** | $465.9M | $343.8M | $205.8M | $247.9M | $381.6M | $353.3M | $214.4M | $143.5M | $277.8M | $245.2M |
| Accounts Payable | $65.07M | $51.65M | $31.72M | $23.04M | $17.56M | $51.98M | $28.86M | $44.89M | $20.38M | $4.59M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $1.04M | $1.71M |
| Deferred Revenue (Current) | $34.48M | $8.52M | $25.40M | $3.51M | $5.68M | $1.66M | $2.15M | -- | -- | -- |
| Other Current Liabilities | -- | -- | $990K | $279K | $167K | $52K | $211K | $296K | $48K | $143K |
| **Total Current Liabilities** | $300.8M | $246.2M | $156.2M | $92.31M | $73.35M | $94.07M | $66.08M | $64.33M | $33.14M | $15.59M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.02M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $634K | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $8.74M | $0 | -- | -- | $0 | $1.29M | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $467.0M | $486.3M | $504.6M | $479.4M | $505.2M | $355.3M | $128.4M | $0 | $0 | $1.02M |
| **Total Liabilities** | $767.9M | $732.5M | $660.8M | $571.7M | $578.5M | $449.4M | $194.5M | $64.33M | $33.14M | $16.61M |
| **Total Debt (incl. Leases)** | $2.75M | $5.31M | $4.57M | $1.05M | $1.92M | $6.04M | $1.56M | -- | $1.04M | $2.73M |
| Common Stock | $245K | $196K | $118K | $75K | $61K | $26K | $27K | $27K | $26K | $23K |
| Retained Earnings | -$1.62B | -$1.60B | -$1.55B | -$1.34B | -$1.11B | -$838.8M | -$695.3M | -$598.1M | -$396.3M | -$229.2M |
| Accumulated Other Comp. Income | $0 | $0 | $0 | -$2.0K | -$31K | $0 | $23K | -$319K | -$845K | -$172K |
| **Total Stockholders' Equity** | -$302.0M | -$388.7M | -$455.0M | -$323.8M | -$196.9M | -$96.13M | $19.95M | $79.12M | $244.7M | $228.6M |
| Total Equity | -$302.0M | -$388.7M | -$455.0M | -$323.8M | -$196.9M | -$96.13M | $19.95M | $79.12M | $244.7M | $228.6M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $156.2M | $167.9M | $92.45M | $86.06M | $114.6M | $144.8M | $144.7M | $189.3M |
| **Cash & Short-Term Investments** | $156.2M | $167.9M | $92.45M | $86.06M | $114.6M | $144.8M | $144.7M | $189.3M |
| Accounts Receivable, Net | $132.4M | $140.2M | $119.0M | $107.7M | $81.29M | $80.14M | $67.82M | $60.36M |
| Inventory | $104.2M | $105.1M | $108.5M | $114.5M | $99.32M | $94.49M | $80.10M | $84.47M |
| **Total Current Assets** | $459.5M | $462.6M | $360.5M | $342.6M | $318.8M | $338.0M | $307.6M | $345.1M |
| Property, Plant & Equipment, Net | $311K | $338K | $175K | $201K | $228K | $254K | $281K | $307K |
| **Total Non-Current Assets** | $3.07M | $3.32M | $3.56M | $4.49M | $5.25M | $5.82M | $6.56M | $7.21M |
| **Total Assets** | $462.5M | $465.9M | $364.0M | $347.1M | $324.0M | $343.8M | $314.1M | $352.3M |
| Accounts Payable | $68.41M | $65.07M | $77.51M | $74.70M | $71.99M | $51.65M | $34.86M | $47.67M |
| Deferred Revenue (Current) | $43.53M | $34.48M | $30.68M | $22.31M | $4.54M | $8.52M | $15.08M | $20.67M |
| **Total Current Liabilities** | $300.4M | $300.8M | $359.0M | $298.8M | $271.0M | $246.2M | $165.9M | $175.3M |
| Other Non-Current Liabilities | $8.74M | $8.74M | $7.44M | $7.44M | -- | $0 | -- | -- |
| **Total Non-Current Liabilities** | $470.1M | $467.0M | $456.3M | $481.8M | $479.3M | $486.3M | $518.5M | $521.2M |
| **Total Liabilities** | $770.5M | $767.9M | $815.4M | $780.6M | $750.2M | $732.5M | $684.3M | $696.5M |
| **Total Debt (incl. Leases)** | $2.56M | $2.75M | $3.15M | $4.05M | $4.79M | $5.31M | $6.04M | $6.66M |
| Common Stock | $257K | $245K | $205K | $200K | $197K | $196K | $195K | $195K |
| Retained Earnings | -$1.65B | -$1.62B | -$1.69B | -$1.65B | -$1.64B | -$1.60B | -$1.58B | -$1.55B |
| Accumulated Other Comp. Income | -- | $0 | -- | -- | -- | $0 | -- | $0 |
| **Total Stockholders' Equity** | -$307.9M | -$302.0M | -$451.4M | -$433.5M | -$426.2M | -$388.7M | -$370.2M | -$344.2M |
| Total Equity | -$307.9M | -$302.0M | -$451.4M | -$433.5M | -$426.2M | -$388.7M | -$370.2M | -$344.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$22.68M | -$51.74M | -$209.2M | -$233.7M | -$269.1M | -$143.6M | -$97.17M | -$201.8M | -$167.0M | -$74.98M |
| Depreciation & Amortization | $105K | $63K | $164K | $500K | $612K | $547K | $319K | $265K | $258K | $252K |
| Stock-Based Compensation | $9.87M | $11.99M | $11.96M | $15.21M | $24.31M | $28.39M | $25.88M | $23.97M | $18.61M | $15.96M |
| Change in Receivables | -$60.05M | -$31.65M | -$14.77M | -$10.79M | -$10.55M | -$12.39M | $0 | -- | -- | -- |
| Change in Inventory | -$10.63M | -$28.87M | -$30.42M | -$807K | -$18.26M | -$16.14M | $0 | $0 | -- | -- |
| Change in Payables | $20.92M | $12.43M | $8.68M | $5.60M | -$34.10M | $23.11M | -$16.05M | $24.45M | $15.76M | $3.89M |
| **Operating Cash Flow** | -$13.09M | -$23.65M | -$135.5M | -$174.8M | -$263.8M | -$85.18M | -$70.34M | -$148.6M | -$131.3M | -$47.73M |
| Capital Expenditure | $0 | -$317K | $0 | $0 | $0 | -$869K | -$953K | -$151K | -$19K | -$94K |
| **Free Cash Flow** | -$13.09M | -$23.97M | -$135.5M | -$174.8M | -$263.8M | -$86.05M | -$71.29M | -$148.8M | -$131.3M | -$47.82M |
| Purchases of Investments | -- | $0 | $0 | -$59.90M | -$50.48M | -$4.42M | -$34.33M | -$25.48M | -$219.6M | -$197.2M |
| **Investing Cash Flow** | $0 | -$317K | $42.50M | $8.10M | -$50.48M | $21.36M | $64.23M | $140.4M | -$35.85M | $10.12M |
| Common Stock Issued | -- | $513K | $4.45M | $90.85M | $9.71M | $0 | $0 | -- | $164.0M | -- |
| Share Repurchases | -- | -- | -- | -- | $0 | -$55.00M | $0 | $0 | -- | -- |
| **Financing Cash Flow** | $36.18M | $86.48M | $50.46M | $32.61M | $268.2M | $201.7M | $136.2M | $10.69M | $163.5M | -$1.56M |
| **Net Change in Cash** | $23.09M | $62.51M | -$42.53M | -$134.1M | -$46.07M | $137.9M | $130.1M | $2.50M | -$3.70M | -$39.17M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$25.20M | $61.83M | -$31.33M | -$12.72M | -$40.45M | -$21.32M | -$29.52M | -$61.92M |
| Depreciation & Amortization | $27K | $26K | $26K | $27K | $26K | $27K | $26K | $10K |
| Stock-Based Compensation | $2.50M | $2.39M | $2.35M | $2.67M | $2.46M | $2.81M | $3.02M | $2.93M |
| Change in Receivables | $7.84M | -$21.21M | -$11.23M | -$26.45M | -$1.15M | -$12.32M | -$7.46M | -$5.75M |
| Change in Inventory | $915K | $3.42M | $5.93M | -$15.14M | -$4.83M | -$14.39M | $4.37M | -$11.37M |
| Change in Payables | $3.34M | -$12.45M | $2.90M | $2.62M | $27.84M | $9.30M | -$12.77M | $19.35M |
| **Operating Cash Flow** | -$27.72M | $45.24M | -$4.29M | -$31.42M | -$22.63M | -$34.95M | -$35.33M | -$7.21M |
| Capital Expenditure | -$189K | $0 | $0 | $0 | $0 | $0 | -$167K | -$77K |
| **Free Cash Flow** | -$27.91M | $45.24M | -$4.29M | -$31.42M | -$22.63M | -$34.95M | -$35.49M | -$7.28M |
| **Investing Cash Flow** | -$189K | $0 | $0 | $0 | $0 | $0 | -$167K | -$77K |
| Common Stock Issued | -- | -- | $0 | $0 | $0 | -$90.16M | $0 | $0 |
| **Financing Cash Flow** | $16.22M | $30.16M | $10.67M | $2.85M | -$7.50M | $35.00M | -$9.10M | -$30.02M |
| **Net Change in Cash** | -$11.69M | $75.41M | $6.39M | -$28.57M | -$30.13M | $44K | -$44.59M | -$37.30M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 15.0% | 16.4% | -133.7% | -237.8% | -289.0% | -53.3% | -62.8% | -- | -- | -- |
| **Net Profit Margin** | -5.6% | -15.6% | -179.9% | -309.6% | -343.0% | -63.1% | -65.5% | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -487.0% | -255.1% | -68.2% | -32.8% |
| Return on Assets (ROA) | -4.9% | -15.0% | -101.7% | -94.2% | -70.5% | -40.6% | -45.3% | -140.7% | -60.1% | -30.6% |
| Current Ratio | 1.54x | 1.37x | 1.29x | 2.67x | 4.48x | 3.68x | 3.20x | 2.22x | 6.15x | 13.70x |
| Quick Ratio | 1.19x | 0.99x | 0.87x | 2.29x | 4.02x | 3.51x | 3.20x | 2.11x | 6.04x | 2.45x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | 0.08x | -- | 0.00x | 0.01x |
| **Revenue Growth (YoY)** | +21.3% | +185.7% | +54.1% | -3.8% | -65.5% | +53.4% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | +10.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -76.6% | -67.6% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 18.1% | 15.0% | -9.7% | -13.2% | -15.4% | 16.4% | 5.6% | 1.8% |
| **Net Profit Margin** | -1.8% | -5.6% | -34.8% | -38.8% | -59.0% | -15.6% | -29.4% | -35.5% |
| Return on Assets (ROA) | -1.6% | -4.9% | -29.1% | -30.0% | -47.3% | -15.0% | -27.6% | -28.0% |
| Current Ratio | 1.53x | 1.54x | 1.00x | 1.15x | 1.18x | 1.37x | 1.85x | 1.97x |
| Quick Ratio | 1.18x | 1.19x | 0.70x | 0.76x | 0.81x | 0.99x | 1.37x | 1.49x |
| **Revenue Growth (YoY)** | +23.2% | +143.7% | +69.1% | +11.6% | -52.8% | +114.3% | +52.0% | +186.3% |
| Operating Income Growth (YoY) | -- | -- | -- | +175.1% | -130.6% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -166.3% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -158.3% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -142.0% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -142.1% | -- | -- | -- |

## Related Companies

[AMTB (Amerant Bancorp Inc.)](https://convexityos.com/fundamentals/AMTB), [BH (Biglari Holdings Inc.)](https://convexityos.com/fundamentals/BH), [RBCAA (Republic Bancorp, Inc.)](https://convexityos.com/fundamentals/RBCAA), [AMBA (Ambarella, Inc.)](https://convexityos.com/fundamentals/AMBA), [PACK (Ranpak Holdings Corp.)](https://convexityos.com/fundamentals/PACK), [OPRT (Oportun Financial Corporation)](https://convexityos.com/fundamentals/OPRT), [STBA (S&t Bancorp, Inc.)](https://convexityos.com/fundamentals/STBA), [CSV (Carriage Services, Inc.)](https://convexityos.com/fundamentals/CSV)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
